Two-step test proposed for combination medicines’ SPCs eligibility

Pharmaceutical companies will find it harder to obtain supplementary protection certificates (SPCs) for so-called ‘combination’ medicines in future if the EU’s highest court follows a recent opinion issued by one of its advisers, an expert in life sciences has said.

Read Complete Article

MITLA is a member of the INPLP

    Subscribe for the latest
    IT Law updates

    Receive the latest IT Law updates straight to your inbox, gain access to our exclusive industry events, keep up to date with MITLA.